Is Immunotherapy Appropriate Here?Video Categories: 2018 AONN Midyear, Immunotherapy, and Video Library
Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.
Dr. Gary Palmer discusses the different profile of tumors and how to make findings as general as possible to better treat the patient.
Drs. Goeffrey Oxnard and Lauren Ritterhouse discuss the need for validation and standardization of Tumor Mutational Burden to make it a robust biomarker, in conjunction with PD-L1, in selecting immunotherapy for their lung cancer patients.